AM-2201 is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University.
10g, 25g, 50g, 100g, 250g, 500g, 1000g
There are no reviews yet.
Be the first to review “AM-2201”
1 2 3 4 5
Your review *
Save my name, email, and website in this browser for the next time I comment.